Doctors for America is trying to join the suit to ensure women can get abortions when their lives or health depend on the ...

Fired employees and conservatives say the gutted research teams’ work aligned with the Trump administration’s “pro-family” messaging.

RFK Jr. is prepared to rework the FDA’s official assessment of the abortion pill mifepristone based at least in part on a questionable report.

Reproductive-rights advocates are pushing back against the review of the abortion medication mifepristone ordered by Health and Human Services (HHS) Secretary Robert F. Kennedy Jr.   Kennedy ...

The National Institutes of Health’s visiting fellows program could be hit hard by the Trump administration’s plan to review ...

“I have asked Marty Makary, who is the director at FDA, to do a complete review and report back,” the HHS secretary revealed ... “largest-known” on the abortion pill – analyzed insurance ...

Though unnamed in the HHS announcement, the legal group involved ... Hospital was requiring religious staff to assist in abortions. The hospital had changed its policy in late 2024, requiring ...

Presented by The Coalition to Strengthen America’s Healthcare — A key anti-abortion group is pressuring a group of Senate ...

While the national spotlight often falls on state-level abortion bans or Supreme Court rulings, a quieter but more ...

The FDA has been tasked with re-evaluating the safety of mifepristone after a flawed report claimed it has a high rate of ...

The first 100 days of a new administration — while only a snapshot — can offer insight into the direction the rest of the ...

Nationwide, more than four in five people who use Title X's services are women, according to HHS. Federal law prohibits clinics from using Title X money to pay for abortions. However, HHS ...